Multi-event December 2014 FDA Recall Drug by Actavis Elizabeth Llc

This Multi-event Class II drug recall was voluntarily initiated by Actavis Elizabeth Llc on December 15, 2014 for the product Drug. The FDA reported the reason for recall as failed capsule/tablet specifications. The product was distributed in Puerto Rico and the recall is currently terminated.

Reported Recall Events

Recall Number: D-0336-2015

Reason for Recall
Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.
Initiated
12-15-2014
Reported
01-14-2015
Quantity
10,857 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Actavis Elizabeth LLC
Gabapentin Capsules, USP, 400 mg, Rx Only, a) 100 capsules per bottle, NDC 14550-513-02, b) 500 Capsules per bottle, NDC 45963-557-50, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA.

Batch or Lot Expiration Information

Lot# s: a) G01889A2 Exp 06/2015, b) G01942A1 Exp 08/2015

Recall Number: D-0337-2015

Reason for Recall
Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.
Initiated
12-15-2014
Reported
01-14-2015
Quantity
24,240 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Actavis Elizabeth LLC
Gabapentin Capsules, USP, 300 mg, Rx Only, 100 capsules per bottle, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA, NDC 45963-556-11

Batch or Lot Expiration Information

Lot# s: G01960A1, Exp 09/2015, G01967A1, Exp 10/2015

Affected Packages Involved in this Recall

Recall Number: D-0338-2015

Reason for Recall
Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.
Initiated
12-15-2014
Reported
01-14-2015
Quantity
29,622 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Actavis Elizabeth LLC
Gabapentin Capsules, USP, 100 mg, Rx Only, a) 100 capsules per bottle, NDC 45963-555-11, b) 500 Capsules per bottle, NDC 45963-555-50, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA.

Batch or Lot Expiration Information

Lot# s: a) G01966A1, Exp 10/2015, b) G02004A1, Exp 03/2016